# Cefoxitin

NDC: 63323-341
Generic name: Cefoxitin Sodium
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: POWDER, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20110706

FDA application: ANDA065414

## Active ingredients

- CEFOXITIN SODIUM: 1 g/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63323-341"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63323-341
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2a9d1e7b-96ee-4e6c-a1e8-47b76b924422